APA (7th ed.) Citation

Strober, B., Patil, D., McLean, R. R., Moore-Clingenpeel, M., Guo, N., Levi, E., & Lebwohl, M. (2022). Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting. Dermatology & Therapy, 12(6), 1351. https://doi.org/10.1007/s13555-022-00740-y

Chicago Style (17th ed.) Citation

Strober, Bruce, Dhaval Patil, Robert R. McLean, Melissa Moore-Clingenpeel, Ning Guo, Eugenia Levi, and Mark Lebwohl. "Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting." Dermatology & Therapy 12, no. 6 (2022): 1351. https://doi.org/10.1007/s13555-022-00740-y.

MLA (9th ed.) Citation

Strober, Bruce, et al. "Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting." Dermatology & Therapy, vol. 12, no. 6, 2022, p. 1351, https://doi.org/10.1007/s13555-022-00740-y.